
Intesity Therapeutics Inc (INTS)
NASDAQ
Fin d'année 31 Décembre 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -120.479 | -63.204 | -102.772 | -217.467 | -124.522 | -147.368 |
Return on Equity (%) | 452.862 | 306.558 | 154.189 | 63.765 | 1226.047 | -202.338 |
Return on Invested Capital (%) | -148.762 | -77.415 | -166.438 | 377.355 | -264.726 | -252.551 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.852 | 0.838 | 0.198 | -0.765 | 0.776 | 0.17 |
Earnings Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.699 | -0.95 |
Cash Per Share | 0.428 | 0.925 | 0.682 | 0.197 | 0.505 | 0.151 |
Working Capital Per Share | 0.84 | 0.822 | 0.152 | -0.806 | 0.678 | 0.094 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.621 | -0.95 |
EBITDA Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.621 | -0.95 |
Free Cash Flow Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.699 | -0.95 |
Fin d'année 31 Décembre 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,81M | 6,82M | 3,41M | 3,41M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 3,41M | N/A | N/A | N/A | N/A | N/A | 13,87M | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 31,27M |
Ratio cours/bénéfice | -1,84 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 11,55 |
Ratio prix/valeur comptable | 10,25 |
Rendement de dividende | - |
Actions en circulation | 15,18M |
Volume moyen (1 semaine) | 13,01k |
Volume moyen (1 mois) | 37,61k |
Variation sur 52 semaines | -59,62% |
Plus haut sur 52 semaines | 5,275 |
Plus bas sur 52 semaines | 1,50 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales